Ambitious Schedule For OTC Monograph Updates On FDA Unified Agenda
This article was originally published in The Tan Sheet
Executive Summary
Nearly two-thirds of FDA’s planned regulatory actions for the consumer health segment would update the OTC drug monograph, including changes to pediatric cough/cold labeling, acetaminophen dosing, oral care products with benzocaine and labeling for some laxatives.